13F filing recap · Q2 2013

What did Brave Warrior Advisors buy in Q2 2013?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.16B

Positions

Estimated turnover

15.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Increased positions

VRXValeant Pharmaceuticals International, Inc.$573.07Mreported value+63.4K shares+1.0%CMPRCimpress Plc$283.91Mreported value+45.2K shares+0.8%ESRXExpress Scripts Holding Co$258.96Mreported value+196.1K shares+4.9%SCHWSchwab Charles Corp$198.78Mreported value+607.2K shares+6.9%ORCLOracle Corporation$187.80Mreported value+732.4K shares+13.6%HALHalliburton Company$183.35Mreported value+2.88M shares+190.3%PRIPrimerica, Inc.$124.90Mreported value+25.2K shares+0.8%CMCSKComcast Corporation$109.48Mreported value+35.9K shares+1.3%

Reduced positions

FISVFiserv Inc$98.09Mreported value-316.7K shares-22.0%ONEHigher One Holdings, Inc.$73.56Mreported value-77.3K shares-1.2%GOOGLAlphabet Inc.$67.80Mreported value-50.2K shares-39.4%

Exited positions

USBUS Bancorp$59.45Mprior reported value-1.75M shares-100.0%